BIOLASE (BLTI) Receives U.S. Patemt Entitled 'Methods for Treating Eye Conditions'
Go back to BIOLASE (BLTI) Receives U.S. Patemt Entitled 'Methods for Treating Eye Conditions'| Biolase Technology, Inc. (NASDAQ: BLTI) | Delayed: 2.42 +0.06 (2.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.36 | 52 Week High | $6.13 | |||
| Open | $2.36 | 52 Week Low | $2.14 | |||
| Day High | $2.49 | P/E | N/A | |||
| Day Low | $2.36 | EPS | $-0.17 | |||
| Volume | 80,153 | |||||
